Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.21 trillion and total revenue of $116.49 billion.
Market Cap
1.21T
Revenue
116.49B
Profits
-35.36B
PE Ratio
n/a
Profit Margin
-30.36%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 122.98B | -4.30% | 1,094,385 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 86.33B | 1.17% | 13,352,579 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 75.20B | -1.27% | 624,694 | 15.53B |
| 4 | ARGX | argenx SE | 49.71B | -1.19% | 272,752 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 40.39B | -2.84% | 2,939,027 | - |
| 6 | ONC | BeOne Medicines AG | 39.69B | -0.38% | 278,258 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 32.53B | -2.09% | 3,380,228 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.95B | -1.41% | 1,118,995 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 24.09B | -3.58% | 6,314,052 | 7.53M |
| 10 | BNTX | BioNTech SE | 22.36B | -7.13% | 1,908,751 | 3.03B |
| 11 | INCY | Incyte Corporation | 22.02B | -2.46% | 2,596,730 | 5.82B |
| 12 | GMAB | Genmab A/S | 21.53B | -2.14% | 3,743,444 | 4.13B |
| 13 | INSM | Insmed Incorporated | 21.14B | -1.80% | 2,161,052 | 1.14B |
| 14 | EXEL | Exelixis, Inc. | 14.75B | -0.52% | 2,624,624 | 2.44B |
| 15 | ASND | Ascendis Pharma A/S | 14.66B | -1.67% | 592,225 | 1.20B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 13.66B | -2.93% | 817,961 | 4.60B |
| 17 | CORT | Corcept Therapeutics Incorporated | 12.73B | -2.80% | 551,411 | 830.81M |
| 18 | HALO | Halozyme Therapeutics, Inc. | 12.44B | -1.31% | 1,780,585 | 1.66B |
| 19 | SMMT | Summit Therapeutics Inc. | 12.41B | -9.40% | 7,111,042 | - |
| 20 | BBIO | BridgeBio Pharma, Inc. | 12.37B | -3.73% | 2,708,370 | 713.07M |
| 21 | TECH | Bio-Techne Corporation | 11.37B | -0.11% | 2,420,212 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.53B | -1.82% | 2,661,580 | 3.41B |
| 23 | PCVX | Vaxcyte, Inc. | 10.51B | -5.45% | 2,246,212 | - |
| 24 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.45B | -3.22% | 243,707 | 1.28B |
| 25 | IBRX | ImmunityBio, Inc. | 10.39B | -3.16% | 11,521,267 | 165.79M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.51B | -3.29% | 281,909 | 440.48M |
| 27 | TWST | Twist Bioscience Corporation | 9.49B | -0.35% | 1,318,864 | 431.80M |
| 28 | PTGX | Protagonist Therapeutics, Inc. | 8.96B | -4.41% | 1,031,819 | 281.99M |
| 29 | KYMR | Kymera Therapeutics, Inc. | 8.87B | -4.82% | 480,634 | 105.00M |
| 30 | CYTK | Cytokinetics, Incorporated | 8.57B | -1.86% | 1,935,738 | 67.67M |
| 31 | CAI | Caris Life Sciences, Inc. | 8.35B | -0.54% | 3,522,971 | 989.61M |
| 32 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.21B | -4.28% | 2,251,443 | 669.50M |
| 33 | AXSM | Axsome Therapeutics, Inc. | 8.19B | -5.83% | 1,242,807 | 776.57M |
| 34 | TGTX | TG Therapeutics, Inc. | 7.71B | -1.68% | 1,001,054 | 799.54M |
| 35 | SYRE | Spyre Therapeutics, Inc. | 7.52B | -6.34% | 1,441,007 | - |
| 36 | ABVX | ABIVAX Société Anonyme | 7.45B | -0.83% | 992,696 | 5.33M |
| 37 | IONS | Ionis Pharmaceuticals, Inc. | 7.04B | -2.95% | 2,982,789 | 874.09M |
| 38 | PRAX | Praxis Precision Medicines, Inc. | 6.79B | -3.20% | 622,134 | 7.46M |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 6.57B | -0.41% | 11,915,444 | 324.97M |
| 40 | BLTE | Belite Bio, Inc | 6.12B | -4.24% | 233,364 | - |
| 41 | LGND | Ligand Pharmaceuticals Incorporated | 6.05B | -2.44% | 203,308 | 290.54M |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.96B | -3.57% | 621,978 | 239.92M |
| 43 | IMVT | Immunovant, Inc. | 5.93B | -2.61% | 944,367 | - |
| 44 | KOD | Kodiak Sciences Inc. | 5.75B | -7.69% | 1,546,531 | - |
| 45 | CGON | CG Oncology, Inc. | 5.53B | -1.16% | 1,184,417 | 6.23M |
| 46 | ORKA | Oruka Therapeutics, Inc. | 5.18B | -2.69% | 490,798 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 5.17B | -7.48% | 762,420 | 618.07M |
| 48 | ERAS | Erasca, Inc. | 5.17B | -4.40% | 5,313,379 | - |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.00B | -4.77% | 1,051,412 | 1.01B |
| 50 | SRRK | Scholar Rock Holding Corporation | 4.93B | -3.39% | 1,096,061 | - |
| 51 | TVTX | Travere Therapeutics, Inc. | 4.88B | -0.42% | 1,668,577 | 591.33M |
| 52 | COGT | Cogent Biosciences, Inc. | 4.88B | -5.67% | 2,298,077 | - |
| 53 | MANE | Veradermics, Incorporated | 4.86B | -5.02% | 503,774 | - |
| 54 | CRSP | CRISPR Therapeutics AG | 4.84B | -2.81% | 1,339,502 | 13.39M |
| 55 | DFTX | Definium Therapeutics, Inc. | 4.62B | -2.33% | 1,998,210 | - |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.34B | -4.89% | 1,315,429 | 1.90M |
| 57 | ABCL | AbCellera Biologics Inc. | 4.09B | -0.20% | 3,250,452 | 66.17M |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 3.94B | -5.64% | 810,104 | - |
| 59 | RLAY | Relay Therapeutics, Inc. | 3.80B | -3.45% | 1,699,708 | 10.35M |
| 60 | TNGX | Tango Therapeutics, Inc. | 3.75B | -8.07% | 9,619,106 | 53.81M |
| 61 | TLX | Telix Pharmaceuticals Limited | 3.62B | -3.28% | 350,091 | 890.79M |
| 62 | LEGN | Legend Biotech Corporation | 3.46B | 0.45% | 2,469,007 | 1.27B |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.33B | -3.88% | 1,104,043 | 7.50M |
| 64 | PBLS | Parabilis Medicines, Inc. | 3.32B | -7.25% | 1,184,957 | 148.00K |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.31B | -4.99% | 1,027,508 | 234.13M |
| 66 | ARQT | Arcutis Biotherapeutics, Inc. | 3.28B | -0.50% | 1,888,180 | 463.98M |
| 67 | ACAD | Acadia Pharmaceuticals Inc. | 3.21B | -4.07% | 2,139,526 | 1.14B |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.11B | -5.96% | 5,676,046 | - |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.11B | -4.81% | 1,208,877 | 606.33M |
| 70 | CELC | Celcuity Inc. | 3.09B | -4.04% | 1,433,087 | - |
| 71 | DNLI | Denali Therapeutics Inc. | 2.94B | -2.90% | 1,361,775 | 3.60M |
| 72 | ELVN | Enliven Therapeutics, Inc. | 2.89B | -3.31% | 847,866 | - |
| 73 | RCUS | Arcus Biosciences, Inc. | 2.87B | -7.52% | 1,390,007 | 117.00M |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.86B | -4.14% | 2,458,588 | - |
| 75 | PGEN | Precigen, Inc. | 2.68B | -2.35% | 2,396,941 | 85.72M |
| 76 | ZLAB | Zai Lab Limited | 2.59B | -6.06% | 728,737 | 449.61M |
| 77 | SLS | SELLAS Life Sciences Group, Inc. | 2.51B | 4.02% | 6,351,649 | - |
| 78 | BEAM | Beam Therapeutics Inc. | 2.44B | -2.79% | 1,666,676 | 156.04M |
| 79 | NAMS | NewAmsterdam Pharma Company N.V. | 2.41B | -4.99% | 834,097 | 7.12M |
| 80 | MBX | MBX Biosciences, Inc. | 2.36B | -5.81% | 768,738 | - |
| 81 | ADMA | ADMA Biologics, Inc. | 2.31B | 1.28% | 3,763,139 | 512.28M |
| 82 | NRIX | Nurix Therapeutics, Inc. | 2.30B | -0.14% | 3,951,453 | 701.94M |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.22B | -4.01% | 1,897,694 | 158.00K |
| 84 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | -1.09% | 1,137,609 | 311.51M |
| 85 | IRON | Disc Medicine, Inc. | 2.17B | -6.42% | 594,915 | - |
| 86 | HRMY | Harmony Biosciences Holdings, Inc. | 2.16B | -3.14% | 1,420,154 | 959.90M |
| 87 | NVAX | Novavax, Inc. | 2.11B | 1.26% | 7,687,626 | 413.80M |
| 88 | PHVS | Pharvaris N.V. | 2.11B | -2.82% | 442,519 | - |
| 89 | VRDN | Viridian Therapeutics, Inc. | 2.06B | -0.44% | 2,122,097 | 71.13M |
| 90 | VCEL | Vericel Corporation | 2.06B | -0.79% | 510,373 | 306.30M |
| 91 | RXRX | Recursion Pharmaceuticals, Inc. | 2.06B | -4.36% | 18,537,599 | 54.86M |
| 92 | IMNM | Immunome, Inc. | 2.00B | -8.20% | 1,882,772 | 4.02M |
| 93 | FTRE | Fortrea Holdings Inc. | 1.99B | -0.38% | 767,655 | 2.68B |
| 94 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | -1.50% | 220,984 | 6.13M |
| 95 | VERA | Vera Therapeutics, Inc. | 1.93B | -3.35% | 2,990,365 | - |
| 96 | LKFT | Lakefront Biotherapeutics NV | 1.89B | -1.76% | 175,966 | 1.13B |
| 97 | URGN | UroGen Pharma Ltd. | 1.87B | -0.05% | 756,981 | 188.73M |
| 98 | MLYS | Mineralys Therapeutics, Inc. | 1.86B | -5.53% | 3,303,787 | - |
| 99 | PVLA | Palvella Therapeutics, Inc. | 1.85B | -4.36% | 215,834 | - |
| 100 | AGIO | Agios Pharmaceuticals, Inc. | 1.80B | -1.98% | 992,141 | 98.34M |
| 101 | VIR | Vir Biotechnology, Inc. | 1.80B | -6.11% | 1,778,112 | 303.23M |
| 102 | MESO | Mesoblast Limited | 1.79B | -2.63% | 259,445 | 120.25M |
| 103 | ZYME | Zymeworks Inc. | 1.78B | -1.03% | 2,022,339 | 37.13M |
| 104 | TRVI | Trevi Therapeutics, Inc. | 1.75B | -4.95% | 1,549,322 | - |
| 105 | XNCR | Xencor, Inc. | 1.75B | -6.07% | 2,422,121 | 104.97M |
| 106 | SRPT | Sarepta Therapeutics, Inc. | 1.74B | -5.33% | 3,674,107 | 1.97B |
| 107 | BHVN | Biohaven Ltd. | 1.72B | -3.30% | 2,434,028 | - |
| 108 | SEPN | Septerna, Inc. | 1.70B | -3.05% | 491,851 | 98.88M |
| 109 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.70B | -7.51% | 3,775,954 | 208.78M |
| 110 | NTLA | Intellia Therapeutics, Inc. | 1.67B | -5.33% | 4,332,905 | 59.51M |
| 111 | NUVB | Nuvation Bio Inc. | 1.66B | -3.67% | 6,972,714 | 169.90M |
| 112 | ZBIO | Zenas BioPharma, Inc. | 1.64B | -4.70% | 519,587 | 1.00M |
| 113 | GPCR | Structure Therapeutics Inc. | 1.59B | -6.69% | 1,433,637 | - |
| 114 | OCUL | Ocular Therapeutix, Inc. | 1.59B | -4.23% | 3,214,220 | 52.06M |
| 115 | BRVE | Braveheart Bio, Inc. | 1.58B | -5.16% | 212,101 | - |
| 116 | GENB | Generate Biomedicines, Inc. | 1.57B | -11.45% | 946,244 | 26.48M |
| 117 | ABSI | Absci Corporation | 1.56B | -5.89% | 2,561,436 | 1.56M |
| 118 | INVA | Innoviva, Inc. | 1.50B | -3.31% | 811,482 | 440.00M |
| 119 | MAZE | Maze Therapeutics, Inc. | 1.48B | -3.75% | 615,115 | 20.00M |
| 120 | QURE | uniQure N.V. | 1.48B | -2.56% | 2,268,770 | 18.67M |
| 121 | RARE | Ultragenyx Pharmaceutical Inc. | 1.47B | -2.48% | 5,300,288 | 717.00M |
| 122 | STOK | Stoke Therapeutics, Inc. | 1.45B | -6.83% | 617,938 | 27.59M |
| 123 | KRSA | Korsana Biosciences, Inc. | 1.44B | -6.99% | 168,852 | - |
| 124 | IMCR | Immunocore Holdings plc | 1.43B | -4.13% | 906,545 | 430.78M |
| 125 | KLRA | Kailera Therapeutics, Inc. | 1.40B | -4.94% | 1,109,982 | - |
| 126 | COAG | Hemab Therapeutics Holdings, Inc. | 1.39B | -1.94% | 441,950 | - |
| 127 | RAPP | Rapport Therapeutics, Inc. | 1.39B | -3.81% | 309,975 | 20.00M |
| 128 | OMER | Omeros Corporation | 1.37B | -3.82% | 993,588 | 38.42M |
| 129 | ANAB | AnaptysBio, Inc. | 1.36B | -0.98% | 416,534 | 106.09M |
| 130 | AAPG | Ascentage Pharma Group International | 1.35B | -1.63% | 10,258 | 94.61M |
| 131 | NKTR | Nektar Therapeutics | 1.29B | -4.82% | 867,759 | 54.59M |
| 132 | GHRS | GH Research PLC | 1.29B | -5.84% | 426,553 | - |
| 133 | INBX | Inhibrx Biosciences, Inc. | 1.28B | -3.97% | 275,306 | 1.30M |
| 134 | TYRA | Tyra Biosciences, Inc. | 1.28B | -5.31% | 364,538 | - |
| 135 | DRTS | Alpha Tau Medical Ltd. | 1.27B | -3.65% | 484,271 | - |
| 136 | SNDX | Syndax Pharmaceuticals, Inc. | 1.25B | -15.71% | 6,800,312 | 252.25M |
| 137 | SVRA | Savara Inc. | 1.21B | -1.24% | 3,741,274 | - |
| 138 | KARD | Kardigan, Inc. | 1.21B | -9.62% | 398,153 | - |
| 139 | ORIC | ORIC Pharmaceuticals, Inc. | 1.17B | -4.23% | 1,157,579 | - |
| 140 | TSHA | Taysha Gene Therapies, Inc. | 1.17B | -13.53% | 6,113,446 | 5.49M |
| 141 | BCAX | Bicara Therapeutics Inc. | 1.15B | 0.06% | 1,263,106 | - |
| 142 | DMRA | Damora Therapeutics, Inc. | 1.15B | -8.37% | 285,195 | - |
| 143 | REPL | Replimune Group, Inc. | 1.14B | -7.35% | 1,262,666 | - |
| 144 | TRAX | First Tracks Biotherapeutics, Inc. | 1.13B | -6.96% | 1,111,967 | - |
| 145 | VOR | Vor Biopharma Inc. | 1.13B | -3.74% | 830,645 | - |
| 146 | LBRX | LB Pharmaceuticals Inc | 1.12B | -3.17% | 297,404 | - |
| 147 | NBTX | Nanobiotix S.A. | 1.08B | -8.93% | 231,273 | 13.15M |
| 148 | AVLN | Avalyn Pharma Inc. | 1.05B | -4.27% | 403,280 | - |
| 149 | JANX | Janux Therapeutics, Inc. | 1.05B | -5.34% | 795,920 | 24.00M |
| 150 | LTGO | Latigo Biotherapeutics, Inc. | 1.04B | -1.94% | 272,646 | - |
| 151 | MNKD | MannKind Corporation | 980.70M | -2.56% | 4,368,936 | 393.63M |
| 152 | MGTX | MeiraGTx Holdings plc | 954.67M | -4.24% | 1,122,036 | 397.50M |
| 153 | IMTX | Immatics N.V. | 933.59M | -5.27% | 897,166 | 47.65M |
| 154 | AKTS | Aktis Oncology, Inc. | 927.73M | -3.81% | 327,651 | 10.06M |
| 155 | CGEM | Cullinan Therapeutics, Inc. | 907.40M | -5.69% | 590,349 | - |
| 156 | MLTX | MoonLake Immunotherapeutics | 885.96M | -2.53% | 2,411,447 | - |
| 157 | RIGL | Rigel Pharmaceuticals, Inc. | 880.57M | -3.42% | 133,998 | 276.79M |
| 158 | KURA | Kura Oncology, Inc. | 874.48M | -5.44% | 2,724,688 | 77.23M |
| 159 | SLBT | SL Science Holding Limited | 872.51M | 1.32% | 120,261 | 3.27M |
| 160 | ANRO | Alto Neuroscience, Inc. | 866.86M | -8.53% | 569,296 | - |
| 161 | SPTX | Seaport Therapeutics, Inc. | 861.84M | -6.12% | 227,200 | - |
| 162 | JBIO | Jade Biosciences, Inc. | 852.84M | -4.21% | 1,331,315 | - |
| 163 | ALMS | Alumis Inc. | 849.10M | -7.08% | 1,899,397 | 7.40M |
| 164 | GLUE | Monte Rosa Therapeutics, Inc. | 843.75M | -5.99% | 2,696,949 | 28.73M |
| 165 | ODTX | Odyssey Therapeutics, Inc. | 826.11M | -5.59% | 258,818 | 99.00K |
| 166 | ABUS | Arbutus Biopharma Corporation | 813.15M | -0.96% | 3,061,072 | 181.72M |
| 167 | SGP | SpyGlass Pharma, Inc. | 800.08M | -3.78% | 63,852 | - |
| 168 | AVBP | ArriVent BioPharma, Inc. | 793.36M | -2.25% | 1,966,974 | - |
| 169 | DNA | Ginkgo Bioworks Holdings, Inc. | 791.92M | -0.25% | 1,858,426 | 132.42M |
| 170 | CRVS | Corvus Pharmaceuticals, Inc. | 791.58M | -6.37% | 1,685,491 | - |
| 171 | ARDX | Ardelyx, Inc. | 777.47M | -3.41% | 6,870,088 | 450.89M |
| 172 | GERN | Geron Corporation | 774.18M | -1.23% | 7,590,432 | 204.56M |
| 173 | HELP | Helus Pharma Inc. | 767.13M | -4.81% | 3,082,447 | - |
| 174 | ANL | Adlai Nortye Group Ltd. | 757.00M | -17.33% | 957,688 | 18.06M |
| 175 | APMD | Apnimed, Inc. | 742.28M | -4.29% | 215,569 | 115.12M |
| 176 | OBX | Obsidian Therapeutics, Inc. | 740.66M | -6.25% | 377,258 | - |
| 177 | ANNX | Annexon, Inc. | 726.09M | -3.28% | 3,343,826 | - |
| 178 | SANA | Sana Biotechnology, Inc. | 721.46M | -8.02% | 4,896,936 | - |
| 179 | IMMX | Immix Biopharma, Inc. | 720.43M | -6.05% | 1,263,716 | - |
| 180 | ACHV | Achieve Life Sciences, Inc. | 720.32M | -0.85% | 1,645,998 | - |
| 181 | LXRX | Lexicon Pharmaceuticals, Inc. | 716.38M | -2.42% | 2,049,798 | 41.47M |
| 182 | GYRE | Gyre Therapeutics, Inc. | 711.49M | -2.26% | 85,200 | 109.82M |
| 183 | CADL | Candel Therapeutics, Inc. | 709.33M | -5.21% | 1,128,033 | - |
| 184 | MDXG | MiMedx Group, Inc. | 685.07M | -2.69% | 972,245 | 355.17M |
| 185 | OABI | OmniAb, Inc. | 683.33M | -1.47% | 809,241 | 38.46M |
| 186 | FDMT | 4D Molecular Therapeutics, Inc. | 682.82M | -4.92% | 991,406 | 92.01M |
| 187 | VSTM | Verastem, Inc. | 674.70M | -9.70% | 2,985,966 | 87.53M |
| 188 | ATTO | Attovia Therapeutics, Inc. | 671.99M | 0.89% | 399,150 | 1.80M |
| 189 | PHAR | Pharming Group N.V. | 657.67M | -1.77% | 28,939 | 366.48M |
| 190 | AURA | Aura Biosciences, Inc. | 650.23M | -4.13% | 1,663,213 | - |
| 191 | AVTX | Avalo Therapeutics, Inc. | 644.10M | -9.29% | 1,648,484 | 59.00K |
| 192 | IVA | Inventiva S.A. | 643.55M | -8.01% | 2,512,163 | 2.81M |
| 193 | SLDB | Solid Biosciences Inc. | 624.05M | -13.26% | 2,868,268 | - |
| 194 | WVE | Wave Life Sciences, Inc. | 618.73M | -4.27% | 3,727,573 | 65.37M |
| 195 | ZVRA | Zevra Therapeutics, Inc. | 617.00M | -8.22% | 1,090,409 | 136.07M |
| 196 | OLMA | Olema Pharmaceuticals, Inc. | 614.23M | -4.62% | 1,420,928 | - |
| 197 | DSGN | Design Therapeutics, Inc. | 612.05M | -10.36% | 724,376 | - |
| 198 | CLYM | Climb Bio, Inc. | 592.17M | -4.80% | 901,180 | - |
| 199 | PRME | Prime Medicine, Inc. | 590.64M | -8.03% | 4,050,795 | 4.07M |
| 200 | NVCT | Nuvectis Pharma, Inc. | 588.75M | -8.23% | 215,308 | - |
| 201 | CRMD | CorMedix Inc. | 576.01M | -0.94% | 1,412,853 | 462.25M |
| 202 | SGMT | Sagimet Biosciences Inc. | 565.85M | -9.32% | 2,524,185 | - |
| 203 | PHAT | Phathom Pharmaceuticals, Inc. | 556.01M | -1.82% | 1,947,143 | 239.66M |
| 204 | FTH | Faeth Therapeutics, Inc. | 555.83M | -7.48% | 350,844 | - |
| 205 | CBIO | Crescent Biopharma, Inc. | 552.56M | -10.72% | 197,106 | 11.88M |
| 206 | STTK | Shattuck Labs, Inc. | 550.99M | -9.85% | 1,576,411 | 1.00M |
| 207 | ETRA | Electra Therapeutics, Inc. | 540.42M | -7.62% | 552,319 | - |
| 208 | SLN | Silence Therapeutics plc | 534.06M | -8.08% | 1,385,762 | 615.00K |
| 209 | PBYI | Puma Biotechnology, Inc. | 522.40M | -1.65% | 295,335 | 231.24M |
| 210 | DBVT | DBV Technologies S.A. | 510.87M | -5.45% | 344,103 | 5.04M |
| 211 | ACRS | Aclaris Therapeutics, Inc. | 510.78M | -3.61% | 3,436,853 | 8.22M |
| 212 | DRUG | Bright Minds Biosciences Inc. | 506.86M | -4.91% | 246,565 | - |
| 213 | CTMX | CytomX Therapeutics, Inc. | 506.62M | -3.93% | 4,752,550 | 18.30M |
| 214 | VALN | Valneva SE | 504.00M | -6.24% | 28,687 | 163.30M |
| 215 | BLSM | BlossomHill Therapeutics, Inc. | 492.03M | -10.36% | 117,887 | - |
| 216 | MNPR | Monopar Therapeutics Inc. | 483.81M | -6.45% | 233,038 | - |
| 217 | RZLT | Rezolute, Inc. | 483.57M | -5.34% | 1,507,641 | - |
| 218 | RGNX | REGENXBIO Inc. | 479.26M | -6.56% | 1,166,741 | 174.48M |
| 219 | PROK | ProKidney Corp. | 474.65M | -5.99% | 1,593,936 | 818.00K |
| 220 | ALT | Altimmune, Inc. | 472.68M | -5.08% | 3,697,581 | 31.00K |
| 221 | OCS | Oculis Holding AG | 470.40M | -3.30% | 320,195 | 1.45M |
| 222 | EPRX | Eupraxia Pharmaceuticals Inc. | 448.08M | -8.74% | 1,522,705 | - |
| 223 | ARVN | Arvinas, Inc. | 447.24M | -8.19% | 851,843 | 316.70M |
| 224 | ALLO | Allogene Therapeutics, Inc. | 445.68M | -7.86% | 6,415,575 | 4.64M |
| 225 | MPLT | MapLight Therapeutics, Inc. | 437.66M | -8.43% | 301,710 | - |
| 226 | AGMB | AgomAb Therapeutics NV | 433.87M | -3.08% | 58,538 | - |
| 227 | ENTX | Entera Bio Ltd. | 433.07M | -6.04% | 754,970 | 42.00K |
| 228 | YDES | YD Bio Limited | 432.07M | -3.63% | 23,596 | 1.24M |
| 229 | NGNE | Neurogene Inc. | 431.45M | -11.78% | 361,928 | 925.00K |
| 230 | AUTL | Autolus Therapeutics plc | 431.18M | -6.90% | 2,414,095 | 117.39M |
| 231 | PRTA | Prothena Corporation plc | 429.18M | -0.83% | 573,203 | 54.53M |
| 232 | OVID | Ovid Therapeutics Inc. | 427.70M | -9.13% | 1,642,440 | 1.58M |
| 233 | DMAC | DiaMedica Therapeutics Inc. | 421.70M | -4.63% | 256,011 | - |
| 234 | TECX | Tectonic Therapeutic, Inc. | 416.60M | -4.65% | 164,021 | - |
| 235 | ASMB | Assembly Biosciences, Inc. | 414.13M | -10.67% | 305,422 | 74.85M |
| 236 | ZURA | Zura Bio Limited | 405.36M | 5.75% | 24,374,842 | - |
| 237 | SPRY | ARS Pharmaceuticals, Inc. | 402.76M | -3.11% | 1,317,091 | 116.93M |
| 238 | CAPR | Capricor Therapeutics, Inc. | 400.00M | -7.90% | 2,630,156 | 11.13M |
| 239 | AVIR | Atea Pharmaceuticals, Inc. | 399.42M | -0.99% | 303,225 | - |
| 240 | EDIT | Editas Medicine, Inc. | 375.50M | -11.09% | 2,238,526 | 47.01M |
| 241 | GALT | Galectin Therapeutics Inc. | 372.14M | -4.65% | 147,715 | - |
| 242 | PRLD | Prelude Therapeutics Incorporated | 366.66M | -4.81% | 672,671 | 22.42M |
| 243 | TRXB | TRex Bio, Inc. | 366.14M | -3.06% | 121,868 | - |
| 244 | EIKN | Eikon Therapeutics, Inc. | 363.99M | -7.44% | 406,701 | - |
| 245 | SCTX | Scribe Therapeutics Inc. | 361.97M | -7.50% | 298,480 | 33.30M |
| 246 | RLMD | Relmada Therapeutics, Inc. | 358.41M | -4.27% | 1,424,267 | - |
| 247 | FENC | Fennec Pharmaceuticals Inc. | 356.98M | -5.04% | 209,498 | 59.22M |
| 248 | KYTX | Kyverna Therapeutics, Inc. | 356.84M | -7.09% | 1,233,673 | - |
| 249 | IRD | Opus Genetics, Inc. | 352.75M | -8.62% | 1,293,573 | 9.86M |
| 250 | VTVT | vTv Therapeutics Inc. | 350.75M | -7.32% | 41,557 | 36.84M |
| 251 | OBIO | Orchestra BioMed Holdings, Inc. | 343.80M | -3.21% | 204,823 | 31.98M |
| 252 | CCCC | C4 Therapeutics, Inc. | 342.01M | -9.15% | 3,820,871 | 35.04M |
| 253 | ARCT | Arcturus Therapeutics Holdings Inc. | 341.93M | -4.60% | 462,800 | 29.37M |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 335.52M | -6.34% | 147,515 | 65.26M |
| 255 | IKT | Inhibikase Therapeutics, Inc. | 320.45M | -4.61% | 1,163,713 | 1.00 |
| 256 | INDP | Indaptus Therapeutics, Inc. | 318.45M | -2.05% | 119,391 | - |
| 257 | CTNM | Contineum Therapeutics, Inc. | 316.77M | -1.69% | 2,647,077 | - |
| 258 | TTRX | Turn Therapeutics Inc. | 315.75M | -4.59% | 117,438 | - |
| 259 | AGEN | Agenus Inc. | 312.89M | -6.46% | 991,684 | 132.69M |
| 260 | ARTV | Artiva Biotherapeutics, Inc. | 307.52M | -7.09% | 526,665 | 251.00K |
| 261 | BNTC | Benitec Biopharma Inc. | 301.04M | -4.85% | 151,396 | - |
| 262 | OCGN | Ocugen, Inc. | 300.25M | -6.52% | 6,859,339 | 4.58M |
| 263 | CABA | Cabaletta Bio, Inc. | 286.53M | -5.59% | 7,933,449 | - |
| 264 | FULC | Fulcrum Therapeutics, Inc. | 281.16M | -1.73% | 1,459,580 | 80.00M |
| 265 | SRZN | Surrozen, Inc. | 276.33M | -5.05% | 867,771 | 11.51M |
| 266 | CUVL | Clinuvel Pharmaceuticals Limited | 266.70M | -2.54% | 4,981 | 65.05M |
| 267 | EYPT | EyePoint, Inc. | 264.67M | -7.53% | 2,499,096 | 2.79M |
| 268 | NAUT | Nautilus Biotechnology, Inc. | 260.87M | -5.53% | 7,253,769 | 190.00K |
| 269 | VNDA | Vanda Pharmaceuticals Inc. | 259.99M | -5.29% | 760,647 | 215.72M |
| 270 | ABEO | Abeona Therapeutics Inc. | 258.47M | -7.76% | 1,794,723 | 25.52M |
| 271 | XFOR | X4 Pharmaceuticals, Inc. | 257.78M | -7.80% | 438,908 | 15.85M |
| 272 | PALI | Palisade Bio, Inc. | 255.31M | -7.86% | 1,580,283 | 500.00K |
| 273 | BCYC | Bicycle Therapeutics plc | 254.07M | -4.47% | 456,760 | 61.21M |
| 274 | RCKT | Rocket Pharmaceuticals, Inc. | 252.48M | -7.26% | 3,889,999 | - |
| 275 | IPSC | Century Therapeutics, Inc. | 249.88M | -4.17% | 560,822 | 109.16M |
| 276 | VOGX | Vogenx, Inc. | 248.97M | -2.22% | 98,725 | - |
| 277 | SABS | SAB Biotherapeutics, Inc. | 243.84M | -5.30% | 891,931 | 114.70K |
| 278 | VCRE | Vicore Pharma Holding AB (publ) | 242.48M | -3.03% | 27,696 | 412.09K |
| 279 | QTTB | Q32 Bio Inc. | 239.94M | -7.78% | 678,609 | 53.74M |
| 280 | FATE | Fate Therapeutics, Inc. | 239.64M | -6.10% | 952,469 | 6.49M |
| 281 | ACIU | AC Immune SA | 239.62M | -1.63% | 194,917 | 21.67M |
| 282 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 236.51M | -9.51% | 504,705 | - |
| 283 | IMRX | Immuneering Corporation | 230.32M | -7.77% | 739,280 | - |
| 284 | LCTX | Lineage Cell Therapeutics, Inc. | 229.72M | -4.80% | 1,784,667 | 13.08M |
| 285 | IFRX | InflaRx N.V. | 228.42M | -2.52% | 367,513 | -11.54K |
| 286 | GLSI | Greenwich LifeSciences, Inc. | 227.51M | -12.77% | 317,077 | - |
| 287 | ZNTL | Zentalis Pharmaceuticals, Inc. | 227.21M | -4.76% | 570,101 | 26.87M |
| 288 | LRMR | Larimar Therapeutics, Inc. | 225.47M | -14.62% | 2,561,876 | - |
| 289 | LXEO | Lexeo Therapeutics, Inc. | 224.80M | -9.87% | 1,586,394 | - |
| 290 | SLGL | Sol-Gel Technologies Ltd. | 223.61M | -5.66% | 33,730 | 1.80M |
| 291 | KROS | Keros Therapeutics, Inc. | 222.66M | -3.27% | 143,812 | 15.01M |
| 292 | PLX | Protalix BioTherapeutics, Inc. | 221.57M | -1.08% | 966,266 | 80.62M |
| 293 | PYXS | Pyxis Oncology, Inc. | 220.99M | -7.96% | 898,882 | 11.04M |
| 294 | MGNX | MacroGenics, Inc. | 217.85M | -8.06% | 559,094 | 175.14M |
| 295 | CAMP | Camp4 Therapeutics Corporation | 215.24M | -6.28% | 88,465 | 4.22M |
| 296 | EVMN | Evommune, Inc. | 213.40M | -2.81% | 804,740 | 10.00M |
| 297 | PRQR | ProQR Therapeutics N.V. | 208.86M | -8.64% | 1,184,046 | 21.05M |
| 298 | ALEC | Alector, Inc. | 208.80M | -10.10% | 2,520,891 | 13.86M |
| 299 | RNAC | Cartesian Therapeutics, Inc. | 198.78M | -6.01% | 99,160 | 1.48M |
| 300 | SION | Sionna Therapeutics, Inc. | 198.03M | -6.61% | 790,165 | - |
| 301 | UPB | Upstream Bio, Inc. | 194.44M | -14.87% | 1,037,348 | 3.16M |
| 302 | ACOG | Alpha Cognition Inc. | 191.65M | -0.45% | 126,034 | 15.26M |
| 303 | IVVD | Invivyd, Inc. | 190.41M | -4.05% | 3,626,422 | 58.37M |
| 304 | ELDN | Eledon Pharmaceuticals, Inc. | 190.34M | -4.10% | 1,167,150 | - |
| 305 | CGEN | Compugen Ltd. | 187.55M | -4.35% | 223,384 | 74.00M |
| 306 | LYEL | Lyell Immunopharma, Inc. | 184.03M | -9.19% | 187,174 | 27.00K |
| 307 | STRO | Sutro Biopharma, Inc. | 182.56M | -17.09% | 406,656 | 45.70M |
| 308 | NGEN | NervGen Pharma Corp. | 175.26M | -5.78% | 492,378 | - |
| 309 | TRDA | Entrada Therapeutics, Inc. | 174.88M | -11.82% | 168,175 | 4.69M |
| 310 | YARW | Yarrow Bioscience, Inc. | 174.88M | -5.17% | 99,829 | - |
| 311 | ORMP | Oramed Pharmaceuticals Inc. | 173.46M | -2.34% | 113,750 | 2.00M |
| 312 | PEPG | PepGen Inc. | 173.15M | 0.40% | 1,181,999 | - |
| 313 | WHWK | Whitehawk Therapeutics, Inc. | 172.17M | -10.65% | 461,219 | 7.15M |
| 314 | VRXA | Veraxa Biotech AG | 169.69M | 5.26% | 740,156 | 29.54K |
| 315 | DTIL | Precision BioSciences, Inc. | 168.37M | -6.58% | 326,681 | 45.06M |
| 316 | CHRS | Coherus Oncology, Inc. | 165.32M | 3.88% | 1,342,018 | 50.94M |
| 317 | ADAG | Adagene Inc. | 165.17M | -10.22% | 228,526 | 9.29M |
| 318 | CNTN | Canton Strategic Holdings, Inc. | 160.96M | -4.27% | 1,012,176 | 1.50M |
| 319 | MDWD | MediWound Ltd. | 157.76M | -2.71% | 80,397 | 11.86M |
| 320 | MSLE | Satellos Bioscience Inc. | 154.92M | -2.72% | 92,912 | - |
| 321 | TARA | Protara Therapeutics, Inc. | 154.83M | -5.42% | 930,130 | - |
| 322 | CMPX | Compass Therapeutics, Inc. | 154.34M | -8.59% | 3,789,927 | 850.00K |
| 323 | MENS | Jyong Biotech Ltd. | 151.44M | -2.86% | 22,949 | - |
| 324 | NKTX | Nkarta, Inc. | 150.41M | -3.23% | 790,533 | - |
| 325 | NBP | NovaBridge Biosciences | 149.64M | -2.27% | 711,271 | - |
| 326 | CDXS | Codexis, Inc. | 144.55M | -6.38% | 747,003 | 77.68M |
| 327 | MOLN | Molecular Partners AG | 143.89M | -3.17% | 1,376 | 856.30K |
| 328 | CUE | Cue Biopharma, Inc. | 142.16M | -20.48% | 300,085 | 37.66M |
| 329 | TLSA | Tiziana Life Sciences Ltd | 140.30M | -0.46% | 492,121 | - |
| 330 | OTLK | Outlook Therapeutics, Inc. | 137.26M | -3.64% | 3,241,409 | -1.16M |
| 331 | AVXL | Anavex Life Sciences Corp. | 137.19M | -1.99% | 1,194,549 | - |
| 332 | ANTX | AN2 Therapeutics, Inc. | 135.85M | -16.28% | 515,048 | - |
| 333 | ALXO | ALX Oncology Holdings Inc. | 135.46M | -22.25% | 992,411 | - |
| 334 | IPHA | Innate Pharma S.A. | 133.28M | -0.68% | 5,334 | 11.21M |
| 335 | RNA | Atrium Therapeutics, Inc. | 132.57M | -5.60% | 218,708 | 35.84M |
| 336 | VYGR | Voyager Therapeutics, Inc. | 132.48M | -5.29% | 1,060,299 | 34.46M |
| 337 | ABOS | Acumen Pharmaceuticals, Inc. | 131.26M | -10.15% | 623,764 | - |
| 338 | KRRO | Korro Bio, Inc. | 129.73M | -5.98% | 264,053 | 2.38M |
| 339 | NERV | Minerva Neurosciences, Inc. | 120.09M | -12.98% | 184,674 | - |
| 340 | SEER | Seer, Inc. | 116.83M | -1.86% | 107,843 | 14.22M |
| 341 | TNYA | Tenaya Therapeutics, Inc. | 116.82M | -7.87% | 2,347,472 | 1.34M |
| 342 | NRXP | NRx Pharmaceuticals, Inc. | 116.81M | -5.26% | 551,696 | 3.39M |
| 343 | SPRB | Spruce Biosciences, Inc. | 115.97M | -5.88% | 110,556 | 697.00K |
| 344 | PDSB | PDS Biotechnology Corporation | 115.96M | 5.26% | 16,852,500 | - |
| 345 | HURA | TuHURA Biosciences, Inc. | 115.35M | -4.74% | 354,258 | - |
| 346 | ARMP | Armata Pharmaceuticals, Inc. | 115.26M | -14.60% | 210,720 | 5.54M |
| 347 | GNLX | Genelux Corporation | 112.93M | -0.98% | 152,252 | 8.00K |
| 348 | TVGN | Tevogen Inc. | 111.89M | 6.46% | 4,273 | - |
| 349 | KZIA | Kazia Therapeutics Limited | 110.18M | -8.74% | 274,684 | 1.27M |
| 350 | FHTX | Foghorn Therapeutics Inc. | 109.86M | -5.13% | 852,266 | 36.74M |
| 351 | ENGN | enGene Therapeutics Inc. | 109.24M | -4.12% | 913,755 | - |
| 352 | MIST | Milestone Pharmaceuticals Inc. | 107.91M | -4.93% | 1,198,065 | 2.34M |
| 353 | CBUS | Cibus, Inc. | 107.76M | -4.73% | 45,275 | 4.35M |
| 354 | LENZ | LENZ Therapeutics, Inc. | 106.83M | -5.82% | 602,187 | 21.48M |
| 355 | VANI | Vivani Medical, Inc. | 106.44M | -0.84% | 269,069 | - |
| 356 | TNXP | Tonix Pharmaceuticals Holding Corp. | 105.14M | -7.68% | 1,133,773 | 29.10M |
| 357 | COYA | Coya Therapeutics, Inc. | 104.97M | -6.96% | 203,993 | 8.02M |
| 358 | UNCY | Unicycive Therapeutics, Inc. | 103.90M | -7.90% | 1,756,738 | - |
| 359 | INO | Inovio Pharmaceuticals, Inc. | 103.21M | -9.67% | 8,538,323 | 65.34K |
| 360 | RANI | Rani Therapeutics Holdings, Inc. | 102.20M | -2.36% | 918,582 | 4.88M |
| 361 | PMVP | PMV Pharmaceuticals, Inc. | 101.94M | -4.26% | 541,254 | - |
| 362 | HUMA | Humacyte, Inc. | 99.70M | -7.88% | 12,177,741 | 2.12M |
| 363 | PYPD | PolyPid Ltd. | 99.12M | -2.79% | 93,332 | - |
| 364 | ICCC | ImmuCell Corporation | 98.00M | 12.40% | 50,463 | 30.68M |
| 365 | RTSN | Retension Pharmaceuticals, Inc. | 96.90M | 2.74% | 137,390 | - |
| 366 | PLYX | Polaryx Therapeutics, Inc. | 96.70M | -3.48% | 13,718 | - |
| 367 | BDTX | Black Diamond Therapeutics, Inc. | 96.52M | -5.08% | 1,135,790 | 70.00M |
| 368 | OKUR | OnKure Therapeutics, Inc. | 94.96M | -3.10% | 232,551 | - |
| 369 | IMUX | Immunic, Inc. | 94.01M | -13.33% | 561,890 | - |
| 370 | CNXU | Conexeu Sciences Inc. | 93.65M | -11.94% | 278,017 | - |
| 371 | ATRA | Atara Biotherapeutics, Inc. | 93.40M | -0.80% | 32,284 | 6.19M |
| 372 | ANIX | Anixa Biosciences, Inc. | 92.82M | -5.99% | 167,681 | - |
| 373 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 92.45M | -9.30% | 647,809 | - |
| 374 | TENX | Tenax Therapeutics, Inc. | 91.65M | -12.57% | 7,387,943 | - |
| 375 | BMEA | Biomea Fusion, Inc. | 91.33M | -7.35% | 6,617,971 | - |
| 376 | RLYB | Rallybio Corporation | 88.79M | -0.42% | 5,183 | 646.00K |
| 377 | AARD | Aardvark Therapeutics, Inc. | 88.41M | -9.21% | 144,280 | - |
| 378 | CLLS | Cellectis S.A. | 86.23M | -6.78% | 54,216 | 63.82M |
| 379 | EQ | Equillium, Inc. | 83.70M | -12.00% | 389,630 | 4.39M |
| 380 | NRXS | NeurAxis, Inc. | 81.63M | -3.27% | 117,917 | 5.32M |
| 381 | TELO | Telomir Pharmaceuticals, Inc. | 80.24M | -0.91% | 53,773 | - |
| 382 | NTRB | Nutriband Inc. | 79.26M | 11.45% | 68,986 | 1.62M |
| 383 | CRDF | Cardiff Oncology, Inc. | 78.57M | -2.88% | 504,724 | 508.00K |
| 384 | PTHS | Pelthos Therapeutics Inc. | 77.68M | 3.94% | 51,819 | 43.30M |
| 385 | PMN | ProMIS Neurosciences, Inc. | 77.66M | -8.36% | 27,044 | - |
| 386 | CGTX | Cognition Therapeutics, Inc. | 76.24M | -6.44% | 3,697,365 | - |
| 387 | OKYO | OKYO Pharma Limited | 75.44M | -0.17% | 20,907 | - |
| 388 | ACRV | Acrivon Therapeutics, Inc. | 74.99M | -7.89% | 477,142 | - |
| 389 | HRTX | Heron Therapeutics, Inc. | 74.16M | -6.02% | 1,861,445 | 151.18M |
| 390 | MNOV | MediciNova, Inc. | 73.83M | -2.60% | 34,751 | 920.48K |
| 391 | MAIA | MAIA Biotechnology, Inc. | 70.56M | -1.69% | 277,464 | - |
| 392 | HYFT | MindWalk Holdings Corp. | 69.73M | 5.71% | 573,720 | 11.57M |
| 393 | NMRA | Neumora Therapeutics, Inc. | 69.56M | -15.34% | 1,485,778 | - |
| 394 | CING | Cingulate Inc. | 68.20M | -3.10% | 73,133 | - |
| 395 | CSBR | Champions Oncology, Inc. | 68.20M | -1.08% | 3,066 | 60.66M |
| 396 | SPRO | Spero Therapeutics, Inc. | 67.26M | -2.12% | 272,491 | 47.00M |
| 397 | OSTX | OS Therapies Incorporated | 66.88M | -7.05% | 792,849 | - |
| 398 | XBIT | XBiotech Inc. | 66.31M | -5.02% | 78,387 | - |
| 399 | RNTX | Rein Therapeutics Inc. | 65.10M | -3.86% | 132,424 | - |
| 400 | FBIO | Fortress Biotech, Inc. | 65.03M | -7.58% | 399,543 | 68.47M |
| 401 | NTHI | NeOnc Technologies Holdings, Inc. | 64.50M | -4.95% | 74,577 | 39.99K |
| 402 | ONCY | Oncolytics Biotech Inc. | 62.48M | 3.53% | 4,111,136 | - |
| 403 | GANX | Gain Therapeutics, Inc. | 61.54M | -10.19% | 781,392 | - |
| 404 | VRCA | Verrica Pharmaceuticals Inc. | 61.50M | -10.72% | 82,791 | 30.32M |
| 405 | XLO | Xilio Therapeutics, Inc. | 60.67M | 1.60% | 18,016 | 64.09M |
| 406 | LONA | LeonaBio, Inc. | 60.58M | 4.30% | 57,013 | - |
| 407 | PLRX | Pliant Therapeutics, Inc. | 59.94M | -1.83% | 273,915 | - |
| 408 | GOSS | Gossamer Bio, Inc. | 59.70M | 5.17% | 480,466 | 53.29M |
| 409 | ALPS | Alps Group Inc | 58.24M | -1.35% | 24,046 | 3.74M |
| 410 | CNTB | Connect Biopharma Holdings Limited | 57.86M | 1.45% | 1,730,555 | 2.95M |
| 411 | BOLD | Boundless Bio, Inc. | 55.27M | -4.71% | 463,157 | - |
| 412 | ACET | Adicet Bio, Inc. | 54.95M | -7.69% | 324,784 | - |
| 413 | ALDX | Aldeyra Therapeutics, Inc. | 54.28M | -0.66% | 1,439,612 | - |
| 414 | GUTS | Fractyl Health, Inc. | 53.39M | -8.73% | 222,657 | 3.00K |
| 415 | KLRS | Kalaris Therapeutics, Inc. | 53.09M | -1.33% | 71,569 | - |
| 416 | ATHE | Alterity Therapeutics Limited | 52.74M | -2.73% | 14,263 | 2.50M |
| 417 | HYPD | Hyperion DeFi, Inc. | 52.21M | -3.17% | 182,631 | 1.40M |
| 418 | INKT | MiNK Therapeutics, Inc. | 52.20M | -2.85% | 7,117 | - |
| 419 | RNXT | RenovoRx, Inc. | 51.90M | -8.00% | 941,373 | 1.98M |
| 420 | ELOX | Eloxx Pharmaceuticals, Inc. | 51.26M | -8.57% | 21,804 | - |
| 421 | MREO | Mereo BioPharma Group plc | 51.10M | 1.52% | 1,256,398 | 500.00K |
| 422 | CRBU | Caribou Biosciences, Inc. | 50.39M | -5.41% | 4,232,685 | 10.04M |
| 423 | IBIO | iBio, Inc. | 50.28M | -13.44% | 1,340,380 | 100.00K |
| 424 | CLNN | Clene Inc. | 48.19M | -7.88% | 114,508 | 197.00K |
| 425 | HOWL | Werewolf Therapeutics, Inc. | 48.17M | 0.95% | 352,897 | 21.00M |
| 426 | IMA | ImageneBio, Inc. | 48.13M | -0.24% | 9,808 | 800.00K |
| 427 | APLM | Apollomics, Inc. | 47.17M | 0.75% | 499 | 8.84M |
| 428 | INMB | INmune Bio Inc. | 46.77M | -5.34% | 247,169 | 50.00K |
| 429 | ELTX | Elicio Therapeutics, Inc. | 46.52M | -5.85% | 217,924 | - |
| 430 | SER | Serina Therapeutics, Inc. | 46.23M | -6.19% | 26,269 | 130.00K |
| 431 | CELU | Celularity Inc. | 46.08M | -3.40% | 50,300 | 18.97M |
| 432 | ANVS | Annovis Bio, Inc. | 45.16M | -7.83% | 842,713 | - |
| 433 | DWTX | Dogwood Therapeutics, Inc. | 44.19M | -5.11% | 107,708 | - |
| 434 | EXOZ | eXoZymes, Inc. | 42.60M | -9.11% | 20,555 | -700.00 |
| 435 | TIL | Instil Bio, Inc. | 42.05M | -5.78% | 27,210 | - |
| 436 | GRCE | Grace Therapeutics, Inc. | 41.86M | -1.49% | 50,659 | - |
| 437 | BSEM | BioStem Technologies, Inc. | 41.82M | -7.79% | 112,253 | 34.59M |
| 438 | EDSA | Edesa Biotech, Inc. | 38.44M | -3.23% | 59,737 | - |
| 439 | VERU | Veru Inc. | 37.34M | -8.94% | 169,154 | 16.89M |
| 440 | LITS | Lite Strategy, Inc. | 36.79M | -0.82% | 293,837 | - |
| 441 | FLNA | Filana Therapeutics, Inc. | 35.91M | -3.39% | 323,355 | - |
| 442 | MGX | Metagenomi Therapeutics, Inc. | 34.65M | -10.07% | 261,837 | 13.56M |
| 443 | ALGS | Aligos Therapeutics, Inc. | 34.41M | -0.36% | 33,969 | 31.52M |
| 444 | CRVO | CervoMed Inc. | 34.32M | -9.56% | 535,459 | 331.30K |
| 445 | IBO | Impact BioMedical Inc. | 34.00M | -1.24% | 8,864 | 35.00K |
| 446 | NNVC | NanoViricides, Inc. | 33.69M | 3.13% | 220,859 | - |
| 447 | BCTX | BriaCell Therapeutics Corp. | 32.79M | -4.13% | 54,087 | - |
| 448 | GRDX | GridAI Technologies Corp. | 32.22M | -2.36% | 58,823 | - |
| 449 | ATNM | Actinium Pharmaceuticals, Inc. | 31.43M | -5.71% | 87,466 | 35.09M |
| 450 | CVM | CEL-SCI Corporation | 30.78M | -4.37% | 217,772 | - |
| 451 | NXTC | NextCure, Inc. | 28.75M | -5.42% | 54,688 | - |
| 452 | RNAZ | TransCode Therapeutics, Inc. | 28.44M | 3.07% | 54,148 | - |
| 453 | IGC | IGC Pharma, Inc. | 27.40M | -3.99% | 398,364 | 1.11M |
| 454 | IMMP | Immutep Limited | 25.95M | -2.72% | 12,182 | 13.79M |
| 455 | ATOS | Atossa Therapeutics, Inc. | 25.55M | 7.17% | 70,737 | - |
| 456 | MCRB | Seres Therapeutics, Inc. | 25.41M | -5.60% | 44,025 | 1.88M |
| 457 | ABVC | ABVC BioPharma, Inc. | 25.38M | -0.08% | 42,355 | 797.92K |
| 458 | CNTX | Context Therapeutics Inc. | 25.27M | -9.84% | 1,252,867 | - |
| 459 | BYSI | BeyondSpring Inc. | 24.95M | -1.43% | 53,412 | 1.88M |
| 460 | KYNB | Kyntra Bio, Inc. | 23.77M | -4.08% | 15,927 | 4.62M |
| 461 | PLRZ | Polyrizon Ltd. | 23.65M | 7.62% | 47,012 | - |
| 462 | QNTM | Quantum BioPharma Ltd. | 23.37M | 2.48% | 82,828 | - |
| 463 | EVAX | Evaxion A/S | 23.02M | -8.00% | 133,395 | 7.49M |
| 464 | COCP | Cocrystal Pharma, Inc. | 20.80M | 1.89% | 85,354 | 330.00K |
| 465 | QNRX | Quoin Pharmaceuticals, Ltd. | 19.94M | -4.82% | 25,809 | - |
| 466 | ATYR | aTyr Pharma, Inc. | 19.73M | -6.38% | 2,614,182 | 190.00K |
| 467 | ICU | SeaStar Medical Holding Corporation | 18.89M | -6.75% | 125,202 | 1.71M |
| 468 | NEUP | Neuphoria Therapeutics Inc. | 18.34M | 2.11% | 26,239 | 1.17M |
| 469 | AKTX | Akari Therapeutics, Plc | 18.05M | -7.49% | 18,432 | - |
| 470 | PBM | Psyence Biomedical Ltd. | 17.36M | -4.01% | 34,110 | - |
| 471 | JSPR | Jasper Therapeutics, Inc. | 16.49M | -10.70% | 422,797 | - |
| 472 | NCEL | NewcelX Ltd. | 16.40M | -2.20% | 5,411 | - |
| 473 | RADX | Radiopharm Theranostics Limited | 16.37M | 8.10% | 143,012 | 8.90M |
| 474 | KPRX | Kiora Pharmaceuticals, Inc. | 15.84M | -2.73% | 2,974 | 20.00K |
| 475 | PTN | Palatin Technologies, Inc. | 15.51M | -4.21% | 14,212 | 13.19M |
| 476 | DYAI | Dyadic International, Inc. | 15.50M | 1.00% | 46,740 | 3.80M |
| 477 | MRKR | Marker Therapeutics, Inc. | 15.42M | -8.43% | 174,322 | 3.55M |
| 478 | BCDA | BioCardia, Inc. | 14.99M | -2.91% | 67,979 | 3.00K |
| 479 | DARE | Daré Bioscience, Inc. | 14.71M | -0.32% | 111,999 | 1.37M |
| 480 | TCRX | TScan Therapeutics, Inc. | 14.69M | -8.91% | 448,317 | 7.11M |
| 481 | KTTA | Pasithea Therapeutics Corp. | 14.03M | -6.15% | 61,145 | - |
| 482 | TVRD | Tvardi Therapeutics, Inc. | 13.87M | -1.89% | 73,431 | - |
| 483 | ALLR | Allarity Therapeutics, Inc. | 13.84M | 1.14% | 111,178 | 345.00K |
| 484 | HIND | Vyome Holdings, Inc. | 13.83M | -1.99% | 9,860 | 129.73K |
| 485 | ESLA | Estrella Immunopharma, Inc. | 13.66M | -4.44% | 314,187 | - |
| 486 | LPCN | Lipocine Inc. | 13.36M | -2.41% | 484,105 | 1.57M |
| 487 | CNSY | Cerenome, Inc. | 13.21M | -3.87% | 116,515 | 4.20M |
| 488 | CLRB | Cellectar Biosciences, Inc. | 13.14M | -2.80% | 491,487 | - |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 13.07M | -3.41% | 192,779 | 7.11M |
| 490 | GTBP | GT Biopharma, Inc. | 11.73M | -4.41% | 29,252 | - |
| 491 | PASG | Passage Bio, Inc. | 11.71M | -20.00% | 14,214 | - |
| 492 | BLRX | BioLineRx Ltd. | 11.66M | - | 11,741 | 1.39M |
| 493 | INAB | IN8bio, Inc. | 11.63M | -4.07% | 62,672 | - |
| 494 | PLUR | Pluri Inc. | 11.60M | -3.08% | 14,916 | 1.02M |
| 495 | INTS | Intensity Therapeutics, Inc. | 11.59M | 7.25% | 116,385 | - |
| 496 | AEON | AEON Biopharma, Inc. | 11.46M | -6.47% | 1,287,926 | - |
| 497 | TPST | Tempest Therapeutics, Inc. | 11.27M | -8.27% | 214,504 | - |
| 498 | ACTU | Actuate Therapeutics, Inc. | 11.20M | -27.56% | 948,512 | - |
| 499 | ENSC | Ensysce Biosciences, Inc. | 11.14M | 2.99% | 1,199,769 | 4.50M |
| 500 | PHIO | Phio Pharmaceuticals Corp. | 10.86M | 1.36% | 68,926 | - |